Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway

FEBS Journal

Volumn 281, Issue 3, 2014, Pages 927-942

  Liao, Xing Hua ^a,b   Lu, Da Lin ^b   Wang, Nan ^a   Liu, Long Yue ^a   Wang, Yue ^a   Li, Yan Qi ^a   Yan, Ting Bao ^a   Sun, Xue Guang ^a   Hu, Peng ^b   Zhang, Tong Cun ^a,b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Estrogen receptor (ER ); MCF 7 cell proliferation; MiR 17; P21; PCNA

Indexed keywords

CYCLINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; MICRORNA; MIR 17; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ESTROGEN RECEPTOR Α (ERΑ); MCF-7 CELL PROLIFERATION; MIR-17; P21; PCNA;

BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; E2F1 TRANSCRIPTION FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; KI-67 ANTIGEN; MCF-7 CELLS; MICRORNAS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897089978     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12658     Document Type: Article

References (55)

1. DeSantis C, Siegel R & Bandi P (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61, 408-418.
2. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K & Bondy CA (2000) Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14, 1725-1730.
3. Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR & Simoncini T (2010) Estrogen receptor-a promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol 24, 2114-2125.
4. Platet N, Cathiard AM, Gleizes M & Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51, 55-67.
5. Clarke RB, Howell A, Potten CS & Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57, 4987-4991.
6. Petersen OW, Høyer PE & van Deurs B (1987) Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47, 5748-5751.
7. Fowler AM & Alarid ET (2007) Amping up estrogen receptors in breast cancer. Breast Cancer Res 9, 305.
8. Sweeney KJ, Swarbrick A, Sutherland RL & Musgrove EA (1998) Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene 16, 2865-2878.
9. Dickson RB, Huff KK, Spencer EM & Lippman ME (1986) Induction of epidermal growth factor-related polypeptides by 17-b-estradiol in MCF-7 human breast cancer cells. Endocrinology 118, 138-142.
10. Yang C, Chen L, Li C, Lynch MC, Brisken C & Schmidt EV (2010) Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. Mol Cell Biol 30, 3111-3125.
11. Adams BD, Furneaux H & White BA (2007) The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-a (ERa) and represses ERa messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21, 1132-1147.
12. Xu Y, Fang F, Zhang J, Josson S, St Clair WH & St Clair DK (2010) miR-17 suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS ONE 22, e14356.
13. Hossain A, Kuo MT & Saunders GF (2006) Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26, 8191-8201.
14. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T, et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182, 509-517.
15. Wong P, Iwasaki M, Somervaille TC, Ficara F, Carico C, Arnold C, Chen CZ & Cleary ML (2010) The miR- 17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res 70, 3833-3842.
16. Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S & Santen RJ (1998) Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 139, 4164-4174.
17. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, et al. (2009) The estrogen receptor-ainduced micro RNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 106, 15732-15737.
18. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B & Grimmond SM (2008) The miR-17-5p micro RNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9, R127.
19. Sutherland RL & Musgrove EA (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9, 95-104.
20. Lukas J, Bartkova J & Bartek J (1996) Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRbcontrolled G1 checkpoint. Mol Cell Biol 16, 6917-6925.
21. Peng J & Jordan VC (2010) Expression of estrogen receptor a with a Tet-off adenoviral system induces G0/ G1 cell cycle arrest in SKBr 3 breast cancer cells. Int J Oncol 36, 451-458.
22. Elayat G, Selim AG & Wells CA (2009) Alterations of the cell cycle regulators cyclin D1, cyclin A, p27, p21, p16, and pRb in apocrine metaplasia of the breast. Breast J 15, 475-482.
23. Russo J & Russo IH (2006) The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102, 89-96.
24. DeGregori J & Johnson DG (2006) Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med. 6, 739-748.
25. Jakesz R, Smith CA, Aitken S, Huff K, Schuette W, Shackney S & Lippman M (1984) Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res 44, 619-625.
26. Ali S & Coombes RC (2000) Estrogen receptor a in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 5, 271-281.
27. Mitropoulou TN, Tzanakakis GN, Kletsas D, Kalofonos HP & Karamanos NK (2003) Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. Int J Cancer 104, 155-160.
28. Kousidou O, Berdiaki A, Kletsas D, Zafiropoulos A, Theocharis AD, Tzanakakis GN & Karamanos NK (2008) Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells. Mol Oncol 2, 223-232.
29. Huderson BP, Duplessis TT, Williams CC, Seger HC, Marsden CG, Pouey KJ, Hill SM & Rowan BG (2012) Stable inhibition of specific estrogen receptor a (ERa) phosphorylation confers increased growth, migration/ invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells. Endocrinology 153, 4144-4159.
30. Sisci D, Aquila S, Middea E, Gentile M, Maggiolini M, Mastroianni F, Montanaro D & Andò S (2004) Fibronectin and type IV collagen activate ERa AF-1 by c-Src pathway: effect on breast cancer cell motility. Oncogene 23, 8920-8930.
31. Hall LC, Salazar EP, Kane SR & Liu N (2008) Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 109, 57-66.
32. Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetzig WM, Gardner AE, Khan SA, et al. (2010) Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci USA 107, 15081-15086.
33. Soria G & Gottifredi V (2010) PCNA-coupled p21 degradation after DNA damage: the exception that confirms the rule? DNA Repair 9, 358-364.
34. Zhao H, Ho PC, Lo YH, Espejo A, Bedford MT, Hung MC & Wang SC (2012) Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. PLoS ONE 7, e29416.
35. Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A & Fotedar R (1999) Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin- proteasome pathway. Oncogene 18, 3290-3302.
36. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P & Barbareschi M (1992) PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 45, 416-419.
37. Wang C, Yu J & Kallen CB (2008) Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells. PLoS ONE 3, e3523.
38. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG & Kushner PJ (2002) Opposing action of estrogen receptors a and b on cyclin D1 gene expression. J Biol Chem 277, 24353-24360.
39. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E & Auricchio F (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15, 1292-1300.
40. Tsonis AI, Afratis N, Gialeli C, Ellina MI, Piperigkou Z, Skandalis SS, Theocharis AD, Tzanakakis GN & Karamanos NK (2013) Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells. FEBS J 280, 2248-2259.
41. Gupta PB & Kuperwasser C (2006) Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 102, 71-78.
42. Chen JQ & Russo J (2009) ERa-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta 796, 162-175.
43. Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y, Li C, Chong M, Ibrahim T, Mercatali L, et al. (2013) miR-126 and miR-126 repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 15, 284-294.
44. Yang K, Handorean AM & Iczkowski KA (2009) MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol 2, 361-369.
45. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP & Pestell RG (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107, 8231-8236.
46. Li H, Bian C, Liao L, Li J & Zhao RC (2011) miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat 126, 565-575.
47. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL & Katzenellenbogen BS (2007) Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol 21, 2112-2123.
48. Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM & MacPherson D (2011) miR-17-92 cooperates with RB pathway mutations to promote retinoblastoma. Genes 25, 1734-1745.
49. Luo XG, Xi T, Guo S, Liu ZP, Wang N, Jiang Y & Zhang TC (2009) Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells. IUBMB Life 61, 679-684.
50. Heid CA, Stevens J, Livak KJ & Williams PM (1996) Real time quantitative PCR. Genome Res 6, 986-994.
51. Wang Z (2011) The guideline of the design and validation of MiRNA mimics. Methods Mol Biol 676, 211-223.
52. Burnette WN (1981) 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate- polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112, 195-203.
53. Liao XH, Wang N, Liu QX, Qin T, Cao B, Cao DS & Zhang TC (2011) Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy. IUBMB Life 63, 54-61.
54. Morley M & Gee DJ (1982) An assessment of the immunofluorescence technique as a method for demonstrating the histological localization of tetrahydrocannabinol in mammalian tissues. J Forensic Sci 27, 837-843.
55. Nordeen SK (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6, 454-458.